Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer.

Scagliotti, GV; Parikh, P; von, Pawel; Biesma, B; Vansteenkiste, J; Manegold, C; Serwatowski, P; Gatzemeier, U; Digumarti, R; Zukin, M; Lee, JS; Mellemgaard, A; Park, K; Patil, S; Rolski, J; Goksel, TUNCAY; de, Marinis; Simms, L; Sugarman, KP; Gandara, D

doi:10.1200/jco.2007.15.0375

Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer.

Scagliotti G., Parikh P., von P., Biesma B., Vansteenkiste J., Manegold C., ...Daha Fazla

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, cilt.26, ss.3543-51, 2008 (SCI İndekslerine Giren Dergi)

Cilt numarası: 26
Basım Tarihi: 2008
Doi Numarası: 10.1200/jco.2007.15.0375
Dergi Adı: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Sayfa Sayıları: ss.3543-51